Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:11 AM
Ignite Modification Date: 2025-12-25 @ 4:11 AM
NCT ID: NCT02068820
Eligibility Criteria: Inclusion Criteria: 1. The patient must be ≥18 and ≤85 years of age. 2. The patient must be female. 3. The patient must be willing and able to provide informed consent. 4. The patient is willing and able to comply with the study protocol. 5. The patient has endometrial cancer and is scheduled for robotic hysterectomy and lymphadenectomy. 6. The patient agrees to follow-up examinations out to 6-weeks post-treatment Exclusion Criteria: 1. The patient is not a candidate for robotic assisted hysterectomy and lymphadenectomy. 2. The patient has known or suspected allergies to iodine, ICG or ISB. 3. The patient has hepatic dysfunction confirmed by elevated liver function studies (i.e., hepatic enzyme SGOT, SGPT or Bilirubin \> 2 x normal (based on reference values from the laboratory used by the patient)
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT02068820
Study Brief:
Protocol Section: NCT02068820